Nome Químico: N-(2-hydroxyethyl)-N-phenylnitrous amide
Sorrisos: OCCN(N=O)C1=CC=CC=C1
Inchi: InChI=1S/C30H44FN3O10S/c1-17(2)23-14-26(34(4)45(5,43)44)32-28(18-6-8-19(31)9-7-18)22(23)11-10-20(36)12-21(37)13-27(40)33(3)15-24(38)29(41)30(42)25(39)16-35/h6-11,14,17,20-21,24-25,29-30,35-39,41-42H,12-13,15-16H2,1-5H3/b11-10+/t20-,21-,24+,25-,29-,30-/m1/s1
Development and validation of stability indicating UPLC method for the determination of Rivaroxaban in bulk and finished products and identification of degradation products by LCMS
By Ali, Syed Mastan; Ramachandran, D.
From Journal of Applicable Chemistry (Lumami, India) (2021), 10(3), 291-301
Validated LC-MS/MS method for the determination of three genotoxic impurities in rivaroxaban drug substance
By Korlakunta, Vijaya Gouri; Dasari, Vijaya Bharathi; Sharma, Hemant Kumar; Nowduri, Annapurna; Bonige, Kishore Babu; Chavakula, Ramadas
From European Journal of Biomedical and Pharmaceutical Sciences (2020), 7(8), 492-500
Development of a stability-indicating HPLC method and a dissolution test for rivaroxaban dosage forms
By Souri, Effat; Mottaghi, Siavash; Zargarpoor, Mohammad; Ahmadkhaniha, Reza; Jalalizadeh, Hassan
From Acta Chromatographica (2016), 28(3), 347-361